Insilico Medicine Is A Biotechnology Company That Utilizes Generative Artificial Intelligence To Enhance Drug Discovery And Developmentfounded In 2014 By Alex Zhavoronkov In Baltimoremarylandthe Company Has Established Itself As A Leader In Ai Driven Pharmaceutical Innovationin 2024Insilico Relocated Its Headquarters To Cambridgemassachusettsto Integrate More Closely With The Local Biotechnology Ecosystem The Company Offers An Ai Platform Called Pharma Aiwhich Includes Tools For Target Discoverygenerative Chemistryand Clinical Trial Accelerationinsilico Medicine Is Actively Developing 31 Therapeutic Assetsfocusing On Conditions Such As Idiopathic Pulmonary Fibrosiscancerand Covid 19The Company Collaborates With Various Pharmaceutical And Biotech Firmsincluding Sanofi And Exelixisto License Its Ai Designed Molecules And Provide Machine Learning Servicesinsilico Medicine Is Committed To Advancing Drug Development While Reducing Reliance On Animal Testing Through Innovative Ai Methodologies
No conferences found for this company.
| Company Name | Insilico Co Ltd |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
